NT-175 by Neogene Therapeutics for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

NT-175 is under clinical development by Neogene Therapeutics and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC).

Dec 26, 2023 - 18:00
NT-175 is under clinical development by Neogene Therapeutics and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC).

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow